All In Biotech

Drug Trial Radar · NCT06907199

Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections

A Multicentric Randomized Trial of Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for the Long-term Management of Cystitis in Women With Recurrent Urinary Tract Infections

Last checked: Nov 20, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 104 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

104

Planned (sponsor's estimate)

Start

Apr 6, 2026

Primary completion

Jul 1, 2028

Study completion Jan 30, 2029

Sponsor

Lead sponsor
University of Texas Southwestern Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Texas; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First posted
Apr 2, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if the drug Nitrofurantoin (NF) taken as a daily antibiotic, works to treat cystitis compared to electrofulguration (EF) and Nitrofurantoin (NF) daily antibiotic.

Conditions

  • Recurrent UTIs
  • Cystitis Recurrent

Interventions

  • Electrofulguration (EF)Procedure

    Nitrofurantoin (NF) daily antibiotic prophylaxis for 6 months plus Electrofulguration.

  • Nitrofurantoin (NF)Drug

    Nitrofurantoin (NF) daily antibiotic prophylaxis given daily for 6 months.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment of cystitis with NF vs EF+NFTime frame: Baseline to 30 months after enrollment to completion of study

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • The University of Kansas

    Kansas City, Kansas · Not yet recruiting

  • UT Southwestern Medical Center

    Dallas, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.